[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work With Us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Making Pharmaceuticals Show
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
MHRA Response to contaminated paediatric medicines

MHRA Response to contaminated paediatric medicines

by Amelia Holmes | Oct 27, 2022 | Blog, GDP/RP, Good Distribution Practice - GDP, MHRA, Training

On the 7th of October The Medicines and Healthcare products Regulatory Agency (MHRA) released a response to contaminated paediatric medicines identified by the WHO region of Africa.

What makes a good RP?

What makes a good RP?

by Sally Cox | Mar 25, 2022 | Blog, Cogent Gold Standard, Cogent Gold Standard, GDP/RP, Good Distribution Practice - GDP, MHRA, RP, Training

What makes a good RP? – The Responsible Person (RP) title is the named person on a Wholesale Distribution Authorisation (WDA).

WDA(H) & Import – New Guidelines:

WDA(H) & Import – New Guidelines:

by Sally Finlayson | Jul 21, 2021 | Blog, Brexit, GDP/RP, MHRA, RP, Training, WDA(H)

Following Brexit and GB leaving the EU the MHRA have advised that GB wholesale dealers now need to appoint an RPi

Global crackdown of illicit medicines and medical devices

Global crackdown of illicit medicines and medical devices

by Sally Finlayson | Jun 8, 2021 | Blog, Cogent Gold Standard, GDP/RP, Training

The MHRA reported today on a global operation which took place at the end of May. See the full report here Co-ordinated by Interpol, the 14th “Operation Pangea” saw over 100 countries joining force. 3 Million illicit medicines were seized valued at £9...
Are you decommissioning products with the correct status?

Are you decommissioning products with the correct status?

by Sally Finlayson | Jun 1, 2021 | Blog, Brexit, Falsified Medicines, FMD, GDP/RP, Good Distribution Practice - GDP

The EMVO has published a Letter of Announcement on using the correct status when decommissioning pharmaceutical products…

GDP Guidelines : Training to ensure everyone is compliant

GDP Guidelines : Training to ensure everyone is compliant

by Sally Finlayson | May 19, 2021 | Blog, GDP/RP, Good Distribution Practice - GDP, RP, Training

It is essential that the whole team understands what those guidelines are and why it is so important to work in them.

« Older Entries
Next Entries »

Recent Posts

  • Are Audit clip boards and checklists obsolete?
  • Major Changes to MHRA Medical Device Registration Fees
  • Major Changes to MHRA Medical Device Registration Fees

Upcoming Courses

  • GDP Audit Online Training on 11 February 2026 10:00 am
  • Introduction to Good Distribution Practice Online Training on 20 February 2026 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 24 February 2026
  • GDP Audit Online Training on 9 March 2026 10:00 am
  • Export Online Training on 12 March 2026 10:00 am

MHRA Alerts & Recalls

Class 3 Medicines Recall: Aspar Pharmaceuticals Ltd, Ibuprofen 200mg Tablets, Ibucalm 200mg tablets, EL(26)A/07
4 February 2026
Class 2 Medicines Recall: Syri Limited, T/A SyriMed, Baclofen 10mg/5ml Oral Solution, EL(26)A/06
3 February 2026
Field Safety Notices: 26-30 January 2026
2 February 2026
Class 2 Medicines Recall: Accord Healthcare Ltd, Carmustine 100 mg Powder and Solvent for Concentrate for Solution for Infusion (1 vial 100mg powder, 1 vial of 3 mL solvent), EL(26)A/05
2 February 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow